IGFBP7 and chronic kidney disease: This study underlined that TIMP2*IGFBP7 was not influenced by a pre-existing CKD that often characterizes these patients, partially solving the issue observed for NGAL, the values of which were higher in urine or sera in CKD patients independently of AKI [24].